Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 7961 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 9011 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 10919 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 10950 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 11136 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 11403 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 11776 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 12230 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 12273 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 12615 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 12845 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 13895 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 15927 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 16536 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | 2818977 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area normalized | female | Diabetic | Neuropathy | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area normalized | female | Diabetic | no neuropathy | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area normalized | female | Pre-diabetic | Neuropathy | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area normalized | female | Pre-diabetic | no neuropathy | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area normalized | male | Diabetic | Neuropathy | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area normalized | male | Diabetic | no neuropathy | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area normalized | male | Normoglycemic | Neuropathy | |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (M-H)- | Peak area normalized | male | Pre-diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 789 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1206 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1300 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1320 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1330 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1354 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1546 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1634 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1661 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1745 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1800 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 1962 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 2144 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 2183 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 2196 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 2264 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 2383 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 2509 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 2956 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 3048 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 3120 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 3284 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 3367 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | 7242 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | Peak area normalized | female | Pre-diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | XANTHOSINE (M+H)+ | Peak area normalized | male | Normoglycemic | no neuropathy |